FDA 483 - Melanie M Hoppers, MD - December 15, 2022

An FDA inspection of Melanie M Hoppers, MD, a clinical investigator in Jackson, TN, revealed significant deficiencies in the conduct and supervision of a clinical study. The firm failed to ensure subject eligibility and was found to have altered laboratory reports, compromising data integrity. These issues indicate a serious lack of oversight in clinical trial practices.